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COMPARISON OF SIX COMMERCIALLY-AVAILABLE DNA POLYMERASES FOR DIRECT PCR
Masashi MIURA, Chihiro TANIGAWA, Yoshito FUJII & Satoshi KANEKO
SUMMARY
The use of a “direct PCR” DNA polymerase enables PCR amplification without any prior DNA purification from blood samples 
due to the enzyme’s resistance to inhibitors present in blood components. Such DNA polymerases are now commercially available. 
We compared the PCR performance of six direct PCR-type DNA polymerases (KOD FX, Mighty Amp, Hemo KlenTaq, Phusion 
Blood II, KAPA Blood, and BIOTAQ) in dried blood eluted from a filter paper with TE buffer. GoTaq Flexi was used as a standard 
DNA polymerase. PCR performance was evaluated by a nested PCR technique for detecting Plasmodium falciparum genomic DNA 
in the presence of the blood components. Although all six DNA polymerases showed resistance to blood components compared to the 
standard Taq polymerase, the KOD FX and BIOTAQ DNA polymerases were resistant to inhibitory blood components at concentrations 
of 40%, and their PCR performance was superior to that of other DNA polymerases. When the reaction mixture contained a mild 
detergent, only KOD FX DNA polymerase retained the original amount of amplified product. These results indicate that KOD FX 
DNA polymerase is the most resistant to inhibitory blood components and/or detergents. Thus, KOD FX DNA polymerase could be 
useful in serological studies to simultaneously detect antibodies and DNA in eluents for antibodies. KOD FX DNA polymerase is thus 
not limited to use in detecting malaria parasites, but could also be employed to detect other blood-borne pathogens. 
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INTRODUCTION
Mutational alteration of DNA polymerases to render them resistant 
to inhibition by blood components led to the development of “direct 
PCR” methods for the analysis of blood and soil samples5. Recently, 
various DNA polymerase kits have become commercially available for 
use in amplifying DNA directly from whole blood. During introduction 
of direct PCR experiments in our laboratory, we noticed a striking 
difference in blood-resistant performance between several kits. However, 
no studies have been conducted to evaluate these differences. We therefore 
compared the PCR performance of six commercially-available direct 
PCR-type DNA polymerases against a standard Taq DNA polymerase 
in the presence of PCR inhibitors found in blood components using a 
diagnostic nested PCR method for the detection of Plasmodium species 
genomic DNA.
Due to the limited infrastructure in many tropical countries, storage 
of blood samples for laboratory diagnosis is logistically complicated. 
Filter papers are often used as a practical means of sampling, storing, 
and transporting blood samples for the detection of blood pathogens such 
as Plasmodium falciparum2,4. The utility of filter paper blood samples 
for the measurement of serum antibodies and diagnostic PCR analyses 
has also been demonstrated3. Thus, we used blood samples eluted from 
dried blood on filter papers to which was added exogenous purified P. 
falciparum genomic DNA to examine the PCR performance and inhibitor 
resistance of the commercial DNA polymerases.
METHODS
DNA polymerases for direct PCR. The six commercially-available 
direct PCR-type DNA polymerases examined in this study were 
purchased from the following suppliers: KOD FX, Toyobo (Tokyo, 
Japan); MightyAmp, Takara bio (Tokyo, Japan); Hemo KlenTaq, New 
England Biolabs (Ipswich, MA, USA); Phusion Blood II, Thermo 
Fisher Scientific (Hudson, NH, USA); KAPA Blood, KAPA Biosystems 
(Woburn, MA, USA); BIOTAQ, Bioline (London, UK). Non-direct PCR-
type standard Taq DNA polymerase (Go Taq Flexi, Promega (Madison, 
WI, USA)) was used as a control.
Preparation of PCR inhibitory blood components. Filter papers 
(ADVANTECH, Tokyo, Japan) containing dried blood obtained from two 
healthy Japanese volunteers were cut into several 2.5-mm diameter disks. 
The blood was eluted by placing each disk in a tube containing 20 µL of 
TE buffer (10 mM Tris-HCl (pH8.0), 0.1 mM EDTA)1 or a PBS-based 
elution buffer containing 0.05% Tween 20 and 0.05% sodium azide as 
used in simultaneous serological and PCR analyses3. The tubes were then 
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heated for 15 min at 50°C, after which the disks were pressed gently 
to the bottom of the tube several times using a new pipette tip for each 
disk, and then heated for 15 min at 97 °C. The tubes were centrifuged 
at 15,000 rpm for 5 min and 1~8 µL of the supernatant (5%~40% blood 
eluent) was used in the 20-µL PCR reaction.
PCR cycling conditions and primers. A slightly modified standard 
nested PCR protocol was used to detect genus-specific Plasmodium 
genomic DNA within the highly conserved regions of the small-subunit 
rRNA gene6,7. The following primers, modified to increase sensitivity, 
were used: rPLU1-MOD1/rPLU5-MOD2 for nest 1 and rPLU3-MOD3/
rPLU4-MOD4 for genus-specific nest 2 amplifications; rPLU1-MOD1: 
GCTTGTCTCAMAGATTAAGCCATGCAAGTGA; rPLU5-MOD2: 
CACAGACCTGTTGTTGCCTTAAACTTCC; rPLU3-MOD3: 
TTTTTWHTATAAGGATAACTACGGAAAAKCTGTAGCTAATAC 
TTG; rPLU4-MOD4: TACCCGTCATAGCCATGTTAGGYCAATACC. 
Changes in the above nucleotide sequences are underlined. Details 
regarding the PCR mixture used in this study are summarized in Table 1.
To ensure maximal performance of each DNA polymerase, the PCR 
conditions recommended by each respective supplier were employed 
(Table 2). In case of PCRs using the Phusion DNA polymerase, we 
employed the PCR protocol for whole blood. Except in the case of 
negative controls, purified P. falciparum (strain 3D7) genomic DNA 
(2 ng) was added to the reaction mixture to serve as the template. For 
all DNA polymerases tested, the nest 2 reaction was performed in a 
similar manner using the nest 1 product (2 µL), with the exception of 
the annealing temperature, which was 58 °C.
All PCR assays were performed using a DNA Thermal Cycler 9700 
(Applied Biosystems, Foster City, CA) with a standard ramp mode. Nest 
2 PCR products (5 µL) were analyzed by gel electrophoresis on 3% 
agarose gels stained with ethidium bromide. Densitometric analysis (NIH 
ImageJ software) was used to determine the relative level of amplified 
target DNA. Amplified target DNA produced at more than 80% of the 
relative densitometric value of the positive control (PCR without blood 
components) were considered indicative of blood component-resistance.
RESULTS
While the non-blood direct DNA polymerase (Go Taq Flexi, 
Promega) did not amplify the target gene region in the presence of 
blood components, all blood-direct DNA polymerases were resistant 
to blood components and produced the target PCR product in reaction 
mixtures containing as much as 10% blood eluent (Fig. 1). No prominent 
differences in the PCR results were observed between blood donors.
Both the KOD FX and BIOTAQ DNA polymerases were resistant 
to the inhibitory effects of blood components in 40% blood eluent 
reaction mixtures, whereas the intensity levels of the target band as 
compared to the positive control in each blood eluent were 83.8% and 
111.1% for KOD FX and 43.0% and 85.5% for BIOTAQ, respectively. 
Table 1
Final composition of PCR mixtures used in this study
The concentrations of nest 1 and 2 were identical.  Each 20-mL reaction mixture for nest 1 amplifications contained 2 ng of P. falciparum genomic 
DNA in the absence or presence of 5%, 10%, 15%, 20%, or 40% blood eluent (or 40% elution buffer). Two microliters of the nest 1 amplification 
product were used as the DNA template for each of the 20-mL amplifications.
KOD FX MightyAmp Hemo KlenTaq Phusion Blood KAPA Blood BIOTAQ Go Taq
5’-primer 0.3 mM 0.3 mM 0.3 mM 0.5 mM 0.5 mM 0.5 mM 0.5 mM
3’-primer 0.3 mM 0.3 mM 0.3 mM 0.5 mM 0.5 mM 0.5 mM 0.5 mM
PCR buffer 1x 1x 1x 1x ‡ 1x§ 1x
dNTP 0.4 mM * 0.2 mM * ‡ * 0.2 mM
DNA polymerase 0.02 units 0.025 units (1.6 mL)† 1 unit (10 mL)† 0.5 units 2 units
*denotes dNTPs were included in the PCR buffer. †denotes indicated volume from each supplier. ‡denotes dNTPs and PCR buffer components were included in the 
DNA polymerase mixture vial. §denotes that the PCR buffer was supplied by SHIMADZU Corporation.
Table 2 
Nest 1 PCR conditions
KOD FX MightyAmp Hemo KlenTaq Phusion Blood KAPA Blood BIOTAQ Go Taq
Initial denaturation 94 °C, 2 min 98 °C, 2 min 95 °C, 3 min 98 °C, 5 min 95 °C, 5 min 95 °C, 10 min 95 °C, 2 min
Denaturation 98 °C, 10 sec 98 °C, 10 sec 95 °C, 20 sec 98 °C, 1 sec 95 °C, 30 sec 94 °C, 30 sec 95 °C, 45 sec
Annealing 55 °C, 30 sec 55 °C, 15 sec 55 °C, 30 sec 55 °C, 5 sec 55 °C, 30 sec 55 °C, 1 min 55 °C, 45 sec
Extension 68 °C, 45 sec 68 °C, 45 sec 68 °C, 45 sec 72 °C, 45 sec 72 °C, 45 sec 72 °C, 45 sec 72 °C, 45 sec
Final extension 68 °C, 7 min 68 °C, 7 min 68 °C, 10 min 72 °C, 1 min 72 °C, 10 min 72 °C, 7 min 72 °C, 5 min
Thirty-five cycles of PCR were performed using each DNA polymerase.
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Fig. 1 - Analysis of the PCR performance of six commercially-available direct PCR-type DNA polymerases in the presence of 5-40% blood components in the reaction mixture. Nested PCR 
cycling conditions recommended by each enzyme’s manufacturer were used. Plasmodium falciparum genomic DNA (2 ng) was detected by PCR using Plasmodium species detection primers 
in the presence of various concentrations of dried blood obtained from two apparently healthy Japanese volunteers that was eluted from filter papers (Left portion of each gel: eluents of blood 
from volunteer #1; right portion of each gel: eluents of blood from volunteer #2). Arrowheads indicate the target PCR product of the 18S ribosomal RNA gene region (240 bp). *Denotes elution 
buffer control (without blood components). The figure shows representative results from two independent experiments.
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Fig. 2 - Analysis of the PCR performance of six commercially-available direct PCR-type DNA polymerases in the presence of 5-40% blood components and mild detergent (0.05% Tween20). 
PCR cycling conditions recommended by each enzyme’s manufacturer were used. Plasmodium falciparum genomic DNA (2 ng) was detected by nested PCR using Plasmodium species 
detection primers in the presence of various concentrations of dried blood obtained from two apparently healthy Japanese volunteers that was eluted from filter papers (Left portion of each 
gel: eluents of blood from volunteer #1; right portion of each gel: eluents of blood from volunteer #2). Arrowheads indicate the target PCR product of the 18S ribosomal RNA gene region (240 
bp). *Denotes elution buffer control (without blood components). The figure shows representative results from two independent experiments.
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Hemo KlenTaq DNA polymerase was resistant to blood components at 
concentrations up to 20%, while Mighty Amp, Phusion Blood II, and 
KAPA Blood DNA polymerases were resistant to blood components 
at concentrations up to 10% of the reaction mixture (Fig. 1). These 
results suggest that of the six commercially-available DNA polymerases 
we tested, KOD FX DNA polymerase is the most resistant to blood 
component inhibitors.
Although some additional high-molecular-weight bands (over 
2,000 base pairs) were produced using KOD FX DNA polymerase, no 
primer dimers (under 100 base pairs) were detected. On the other hand, 
BIOTAQ DNA polymerase produced no detectable high-molecular-
weight additional bands, but the formation of primer dimers was 
observed in the negative control (without template DNA) and 40% 
blood eluent samples.
It has been shown that dried blood spotted onto filter paper is 
suitable for laboratory diagnostic procedures involving PCR analysis 
combined with immunoglobulin detection3. Therefore, we also examined 
the performance of the six commercially-available DNA polymerases 
in combined diagnostic tests using a phosphate buffered saline-based 
elution buffer containing a mild detergent (0.05% Tween 20). As shown in 
Figure 2, KOD FX DNA polymerase was resistant to blood components 
from one of the donors at concentrations up to 20%, and from the other 
donor at concentrations up to 15%. A DNA band of similar intensity 
level (88.5% as compared to the control band) was produced in the 
40% elution buffer sample without blood components, suggesting that 
the activity of KOD FX DNA polymerase is not affected by Tween 20. 
The other DNA polymerases were not resistant to the 40% elution buffer 
containing 0.05% Tween 20, clearly demonstrating the superiority of the 
KOD FX DNA polymerase for assays of this type.
DISCUSSION
It is both time-consuming and costly to determine which direct PCR 
DNA polymerase would be the most suitable for detecting a target gene 
from a specific pathogen. However, our data highlight the importance 
of comparing the performance of several DNA polymerases prior 
to establishing PCR conditions. The PCR fidelity of KOD FX DNA 
polymerase is reportedly more than 10-fold higher than that of standard 
Taq DNA polymerases, and similar to that of Pfu DNA polymerase. 
The high fidelity of KOD FX DNA polymerase results in more accurate 
PCR analyses8,9.
Our results indicate that among the commercially available 
polymerases we tested, KOD FX DNA polymerase has the highest 
potential for resistance to blood components, making it the most 
suitable enzyme for attempting to detect the genomic DNA of pathogens 
in samples containing high concentrations of blood. Theoretically, 
employing DNA polymerases with higher resistance to blood components 
would enable researchers to perform PCR assays with sensitivity high 
enough for large-scale epidemiological studies. In addition, because 
of its resistance to mild detergents such as Tween 20, KOD FX DNA 
polymerase could be useful in serological studies to simultaneously 
detect both antibodies and DNA in eluents used in testing for antibodies.
However, KOD FX DNA polymerase retains 3’ to 5’ exonuclease 
activity, which potentially leads to a non-specific binding between 
primers and contaminated human genomic DNA (Toyobo web site: 
http://www.toyobo.co.jp/seihin/xr/lifescience/products/product/jisshirei/
archives/2008/04/pcr3pcr.html). Therefore, we can not exclude the 
possibility of 3’ to 5’ exonuclease activity of the enzymes (KOD FX) 
leading to the non-specific band (240 bp) in the negative control (Fig. 1) 
was involved. In this line, KOD FX may not be suitable for PCR using 
primers such as targeting the ribosomal RNA gene.
In PCR protocols, we did not employ modifications of the 
recommendation of the manufacturers, which might give better results. 
Indeed, FUEHRER et al. reported a modified protocol for Phusion Direct 
PCR4. Such a modification method should be applied for each PCR 
enzyme to achieve more improved results.
The results of the present study suggest that the increased PCR 
sensitivity of KOD FX DNA polymerase may aid diagnostic field research 
efforts that involve the analysis of large numbers of samples for the 
presence of P. falciparum and other Plasmodium species. Our results 
suggest that this enzyme could also be employed for the detection of 
other blood-borne pathogens.
RESUMO
Comparação de seis polimerases de DNA disponíveis 
comercialmente para o PCR direto
O propósito deste estudo foi avaliar 6 polimerases de DNA 
disponíveis comercialmente que são resistentes aos inibidores do PCR 
para uma amplificação potencial de DNA de amostras de sangue total. O 
DNA genômico do parasita humano da malária, Plasmodium falciparum, 
foi analisado sob condições que incluíram os componentes inibidores do 
sangue extraído de sangue ressacado em papel de filtro. Nossos resultados 
sugerem que a polimerase KOD FX DNA é superior a outras polimerases.
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